On April 17, four
tobacco consortiums initiated legal action against the Australian Federal
Government over Labor’s world first laws requiring all cigarettes to be sold in
plain generic packages. The hearing took place at the High Court of Australia
over three days and has been closely
watched by other countries and tobacco firms who are concerned the Australian
plain packaging legislation may set a global precedent.
The latest anti-tobacco legislation
represents the final blow to an already heavily regulated Australian industry
which, in the past few years, has experienced tax hikes, the compulsory
provisioning of graphic health warnings on tobacco products and restrictions
preventing retailers from displaying cigarette products. Not to mention the
restrictions that have been placed on smoking within many public areas
around Australia.
However, the issue in this case is that the
High Court will give limited consideration to the effectiveness of the laws in
reducing the incidence of smoking uptake and cessation, rather its ruling will
be based on whether the destruction of the tobacco consortium's goodwill is
constitutional. This is a little disturbing because this legislation has been
passed and is currently being challenged without due consideration of the
consequences.
So in the absence of due consideration lets blow the dust of our economic text books and prosecute the consequences of this legislation? Economic theory assumes that
consumers know what is best for them. This concept is known as 'consumer
sovereignty'. According to this economic framework, if smokers freely and
willingly consume tobacco with full information about the health consequences
and addictive potential, and if they also bear all the costs and benefits of
their choices, then the market could be described as operating efficiently and
there would be little grounds for the government to intervene.
Economists and most people within
the wider community agree that this is not the case due to three market
failures: information failure about the health risks of smoking; failures
resulting from the addictiveness of smoking; and the external costs of smoking
or externalities i.e. passive smoking and health costs.
Without going into the detail,
previous laws have been effective in addressing these market failures. And like
the preceding laws, generic packaging is aimed at reducing external costs by
reducing the utility (level of satisfaction) and subsequent demand of the product and increasing the awareness of adverse
health effects while reducing misleading perceptions around branding, e.g. the
misconception that Marlboro gold is less harmful than higher strength
cigarettes.
Despite the good intentions of the legislation it has been implemented when the impacts of generic plain packaging on
tobacco cessation and uptake are not fully understood, meaning the legislation may not be effective in achieving it's intended economic objectives. The most recent
literature review produced by the Cancer Council of Australia brings together
24 studies over two decades. Yet, the studies are mostly from different countries and are experimental in nature, hence the impact has only been tested on samples at a specific point in time.
Virtually all the findings of the
studies converge on the following conclusions.
“Plain and generic packaging of
tobacco products (all other things being equal), through its impact on image
formation and retention, recall and recognition, knowledge, and consumer
attitudes and perceived utilities, would likely depress the incidence of
smoking uptake by non-smoking teens, and increase the incidence of smoking
cessation by teen and adult smokers”.
But as mentioned above, the
caveat attached to the results is that, “this impact would vary across the
population. The extent of change in incidence is impossible to assess except
through field experiments conducted over time”.
It seems ludicrous that no one
considered that the population and tobacco market within Australia is
considerably different to samples from international studies during the
development and provisioning of this legislation. Politicians and the public
have been hoodwinked by the Cancer Council, which has effectively created an
argument around equivocal evidence with limited relevance in an Australian
context.
Firstly, the experiments do not
consider the ‘no display policy’ within Australian retail outlets that supply
tobacco. When a smoker purchases a product from a store they are unable to see
their preferred brand or label. Hence, a generic pack may not cause a further
reduction in utility for current smokers because they cannot actually see the
packaging at the time of the purchase. Subsequently, it would be expected that there would be no further impact on
the incidence of smoking cessation within current smokers.
Secondly, while the removal of
brands may reduce the utility attached to specific brands for new smokers, it will not
reduce the utility of smoking. To get this concept across picture the scene from Pulp Fiction where Vincent and Jules are arguing about the meaning and pleasure of a foot massage – "touchin' his wife's feet, and stickin' your tongue in her Holiest of Holies, ain't the same fuckin' ballpark, it ain't the same league, it ain't even the same fuckin' sport". Likewise, a cigarette achieves a certain state
of mind and happiness which is not comparable to the utility achieved by any other alternative
good or service. A person can not, and will not, substitute to three cans of coke, Mc'donalds burgers, or whatever because it 'aint the same fuckin' ballpark'.
However, the most significant
aspect that has been overlooked within the research is the battle which would
take place between incumbent tobacco consortiums and oligopolist supermarkets –
Coles and Woolworths. In supermarkets and subsidiary petrol stations, the sales
contribution of tobacco is equal to approximately 7 and 30 precent
respectively. According to Richard Dennis of the Australian Institute, an
independent think tank, this in conjunction with the generic packaging was the
incentive needed for Coles and Woolworths to vertically integrate within the
tobacco industry and increase profits. But first Coles and Woolworths would
need to ensure generic labelling laws were passed.
So it would come as
no surprise that in August 2010 Coles and Woolworths both withdrew funding from the tobacco
industry’s war chest which was creating awareness about the ineffectiveness of plain
packaging via commercials in what can only be viewed as a direct attack on
tobacco consortiums.
Around this time, Coles began
importing home-brand-style packs of 25 cigarettes at around $11, almost $4 a
pack less than Australian-made Winfield and other leading brands.
The strategies implemented by the
supermarkets so far are exactly reminiscent of a typical new firm entering an
oligopoly. It is hard to see how government and the Cancer Council over looked it. But, they blatantly
did, in fact they did not even consider it. Anita Dessaix from the Cancer Council
of NSW was shocked when she heard the news that Coles was selling their own line of cigarettes, "this is sneaky and disappointing," she said.
So in lieu of the Cancer Council
anticipating anything, what should we expect in terms of firm behaviour if the
High Court rules in favour of the legislation? In a typical market, tobacco
consortiums could use their goodwill to compete with Coles and Woolworths and
possibly force them out of the market. But in a generic labelled marketing
environment, it is likely only existing smokers would stick with brand labels.
The opportunity for Coles and Woolworths lies in producing cheap cigarettes for
new smokers that have not been exposed to tobacco brands and smokers that have
a price elastic demand function, that is customers struggling to buy cigarettes
after the tax increase.
This strategy will be
complimented with a strategy that aims at promoting their own products, which
is akin to a pharmacist offering generic labels. And by the looks of things,
this has already been implemented. A Coles employee, who preferred to remain
anonymous said "when customers came in and complained that their usual
cigarettes are too expensive we suggest they try one of the new ones, like
Tradition".
The rational strategy for tobacco
consortiums would be only to slightly discount well known brands because these
will still produce revenue within the medium term on the back of current
smokers. It is also likely that they will reduce the price of other cigarettes
to compete with Coles, and Woolworths if it enters the market. Some of you may
be asking, wouldn’t the rational strategy of the tobacco consortiums be an all
out price war? But a price war would be dubious because the government would
just increase taxes to negate the adverse increase in quantity demanded. Secondly,
it is likely big brands will still maintain customers into the medium term
based on the ‘no display’ rationale discussed previously.
In a nutshell, Australia will act
as a petri-dish for the rest of the world on the back of equivocal evidence. Effectively
there is likely to be a negligible impact in the incidence of cessation and an
unknown impact on the incidence of smoking uptake, especially because
particular brands will be heavily subsidised by the supermarkets. Meanwhile,
the law will propagate the supermarket oligopoly, which we are already
concerned about within Australia. Not to mention the economic risk surrounding
the provisioning of a Band-Aid policy such as a price ceiling, which would have
a number of adverse impacts.
The irony of all this is that generic
packs have been provisioned to rectify imperfect information, yet this law has
been developed and provisioned on the back of a body of research, which is a few
cigarettes short of a pack.
No comments:
Post a Comment